Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling

Qian Dua Department of Gastroenterology and Hepatology, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People’s Republic of China;b Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, People’s Republic of ChinaView further author information

Meiying Zhangb Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, People’s Republic of ChinaView further author information

Aiai Gaob Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, People’s Republic of ChinaView further author information

Tao Hec Department of Pathology, Characteristic Medical Center of the Chinese People’s Armed Police Force, Tianjin, People’s Republic of ChinaView further author information

Mingzhou Guob Department of Gastroenterology and Hepatology, the First Medical Center, Chinese PLA General Hospital, Beijing, People’s Republic of China;d National Key Laboratory of Kidney Diseases, the First Medical Center, Chinese PLA General Hospital, Beijing, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-9445-9984 View further author information

Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling

supplementary Table 1.docx

supplementary Figure1.tif

supplementary.xlsx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling

supplementary Table 1.docx

supplementary Figure1.tif

supplementary.xlsx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date